News | News By Subject | News by Disease News By Date | Search News

Cervical cancer News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Amgen (AMGN), Allergan (AGN) Make History With First Cancer Biosimilar OK—Will Take on Genentech (RHHBY)'s $6 Billion Best-Seller     9/18/2017
Death Forces FDA to Place Clinical Hold on Advaxis (ADXS) Cancer Drug     10/8/2015
Top 10 Best-Selling Biotech Drugs     10/2/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Hundreds Of Girls Struck With Mystery Illness; Possibly Linked To Merck & Co. (MRK)'s Gardasil     8/29/2014
San Diego Startup, Hera Therapeutics, Unveils Drug For Viral Infections Tied To Cervical Cancer     8/25/2014
Genentech (RHHBY) Wins Approval To Treat Advanced Cervical Cancer     8/15/2014
Roche (RHHBY)'s Avastin Wins Priority Review For Cervical Cancer     7/15/2014
Pfizer Inc. (PFE) Takes Its Shot at a Vaccine for Evasive MRSA Superbug     5/23/2013
Inovio Pharmaceuticals (INO)'s Cervical Cancer Vaccine Shows Early Promise     10/12/2012
Studies Show GlaxoSmithKline (GSK)'s HPV Vaccine Fights Cervical Cancer     11/9/2011
Merck & Co., Inc. (MRK) Receives Approval to Market GARDASIL(R), ZOLINZA(R) and CUBICIN(R) in Japan     7/1/2011
Merck & Co., Inc. (MRK)'s Gardasil Cuts Rate of Cervical Abnormalities     6/20/2011

News from Around the Web
New Tech Promises Easier Cervical Cancer Screening, Duke University Study     6/1/2017
Robot Radiology: Low Cost A.I. Could Screen For Cervical Cancer Better Than Humans, Lehigh University Study     4/25/2017
Israeli Medical Company Hopes To Save Thousands Of Women’s Lives Per Year, Illumigyn Reveals     5/16/2016
HPV Infection Can Be Identified In Self-Collected Vaginal Swabs, University of New South Wales Study     5/2/2016
Cervical Cancer Screening With A Cellphone     10/30/2015
In Cervical Cancer Fight, 1 Shot Could be Enough, Study Published in Cancer Prevention Research Reveals     11/4/2013
HIV Drug Could Prevent Cervical Cancer, University of Manchester Study     5/3/2011
Oral Sex linked to Cancer Risk, Ohio State University Study Finds     2/23/2011
Male Circumcision Cuts Women's Cervical Cancer Risk, Johns Hopkins University Study     1/7/2011
Breast Cancer Drugs May Fight Cervical Cancer, University of Wisconsin-Madison Study     11/10/2009
Old, New Pap Methods Equally Good, Radboud University Nijmegen Medical Centre Study Finds     10/28/2009
Giving Gardasil to Boys Not Worth the Cost, Harvard School of Public Health Study     10/9/2009
Few Side Effects Found From Radiation Treatment Given After Prostate Cancer Surgery, Mayo Clinic Study     9/29/2009
Merck & Co., Inc. (MRK)'s Cervical Cancer Vaccine Benefits Older Women, Colombian Study     6/2/2009
New Technique May Improve Early Cervical Cancer Treatment, University of Leipzig Study     6/2/2009

Press Releases
Iovance Biotherapeutics Announces Approval Of First Clinical Trial Application By Competent Authority In Netherlands For A Phase II Trial Of LN-145 For The Treatment Of Patients With Cervical Cancer     9/13/2017
Genesis Cancercare Queensland Is First In Asia-Pacific Region To Use Elekta's Venezia Brachytherapy Applicator     9/11/2017
Seattle Genetics (SGEN) Highlights Promising Data With Tisotumab Vedotin In Cervical Cancer At ESMO 2017 Congress     9/8/2017
Iovance Biotherapeutics Announces First Patient Dosed In C-145-04 Phase II Trial In Cervical Cancer     8/16/2017
Guided Therapeutics Re-Establishes Communications With U.S. FDA And Discusses Plan For Refiling For Approval Of The Luviva Advanced Cervical Scan     7/18/2017
Genexine Co. Ltd. Receives Approval To Initiate Phase Ib/II Trial Of GX-188E, HPV Therapeutic DNA Vaccine, In Combination With KEYTRUDA (Pembrolizumab), For The Treatment Of HPV-Induced Cervical Cancer     6/19/2017
Inovio Pharma (INO) Begins Phase III Clinical Trial Of VGX-3100 For The Treatment Of HPV-Related Cervical Pre-Cancer     6/8/2017
Advaxis (ADXS) And Bristol-Myers Squibb (BMY) Announce Clinical Collaboration To Evaluate ADXS-DUAL And Opdivo (Nivolumab) In Metastatic Cervical Cancer     5/30/2017
Updated Results Of Cervical Cancer Study Sponsored By ISA Pharmaceuticals To Be Presented At ASCO 2017     5/23/2017
Mel-Mont Medical Announces The Development Of Mía By XytoTest, A Self-Collected Cervical Sample That Seeks To Eradicate Cervical Cancer     5/17/2017
Advaxis (ADXS) Release: EMA Certification Paves The Way For The MAA Submission For Axalimogene Filolisbac In Metastatic Cervical Cancer     3/23/2017
Results Of Cervical Cancer Study Sponsored By ISA Pharmaceuticals To Be Presented At ASCO-SITC     2/17/2017
Advaxis (ADXS) Release: GOG-0265 Study In Metastatic Cervical Cancer Selected For Late-Breaking Data Presentation At The Society Of Gynecologic Oncology’s Annual Meeting On Women’s Cancer     1/30/2017
Yaohua Medical Instrument Inks Agreement For Cervical Cancer Scan In China     1/30/2017
Advaxis (ADXS) Release: New Published Research Reveals That Cervical Cancer Mortality Rates May Be Significantly Higher In The United States Than Previously Reported     1/25/2017